(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 27 Feb 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | $101.09 | |||
Short term investments | ||||
Net receivables | $1298.7 | $1534.95 | ||
Inventory | $108.56 | $114.02 | ||
Total current assets | $1550.04 | $1708.73 | ||
Long term investments | ||||
Property, plant & equipment | $521.26 | $505.11 | ||
Goodwill & intangible assets | $420.94 | |||
Total noncurrent assets | $966.85 | |||
Total investments | ||||
Total assets | $2516.89 | $2664.16 | ||
Current liabilities | ||||
Accounts payable | $222.12 | $215.28 | ||
Deferred revenue | $39.12 | |||
Short long term debt | $49.52 | |||
Total current liabilities | $506.3 | $488.82 | ||
Long term debt | $791.41 | $949.41 | ||
Total noncurrent liabilities | $955.92 | |||
Total debt | $885.04 | |||
Total liabilities | $1462.23 | $1610.22 | ||
Shareholders' equity | ||||
Retained earnings | $1040.29 | $1026.57 | ||
Other shareholder equity | -$1.55 | -$1.55 | ||
Total shareholder equity | $1054.66 |
(in millions $) | 31 Jan 2025 | 31 Jan 2024 | 28 Feb 2023 | 31 Dec 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $101.09 | $224.19 | $310.76 | |
Short term investments | ||||
Net receivables | $1243.26 | $1114.87 | $895.9 | |
Inventory | $108.56 | $114.97 | $81.29 | |
Total current assets | $1550.04 | $1492.68 | $1356.09 | |
Long term investments | ||||
Property, plant & equipment | $521.26 | $435.09 | $355.9 | |
Goodwill & intangible assets | $420.94 | $359.11 | $374.32 | |
Total noncurrent assets | $966.85 | $820.57 | $762.13 | |
Total investments | ||||
Total assets | $2516.89 | $2313.25 | $2118.22 | |
Current liabilities | ||||
Accounts payable | $222.12 | $207.74 | $155.9 | |
Deferred revenue | $39.12 | $19.51 | $18.51 | |
Short long term debt | $49.52 | $45.03 | $42.14 | |
Total current liabilities | $506.3 | $469.55 | $381.8 | |
Long term debt | $835.52 | $807.37 | $859.77 | |
Total noncurrent liabilities | $955.92 | $974.95 | $977.88 | |
Total debt | $885.04 | $892.02 | $901.91 | |
Total liabilities | $1462.23 | $1444.5 | $1359.68 | |
Shareholders' equity | ||||
Retained earnings | $1040.29 | $855.09 | $748.41 | |
Other shareholder equity | -$1.55 | -$1.77 | -$1.77 | |
Total shareholder equity | $1054.66 | $868.75 | $758.54 |
(in millions $) | 31 Jan 2025 | 30 Oct 2024 | 27 Feb 2024 | 28 Nov 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $952.46 | $1136.11 | ||
Cost of revenue | ||||
Gross Profit | $161.08 | $249.45 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $118.28 | $130.03 | ||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $8.36 | $28.63 | ||
Interest expense | -$15 | -$13.95 | ||
Net income | ||||
Net income | $23.42 | $83.74 | ||
Income (for common shares) |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4175.57 | $3808.46 | $3130.52 | $3199.16 |
Cost of revenue | $3361.82 | $3160.26 | $2633.88 | $2641.99 |
Gross Profit | $813.76 | $648.2 | $496.64 | $557.18 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $327.67 | $293.48 | $262.43 | $259.77 |
Total operating expenses | $490.77 | $437.66 | $415.08 | $488.93 |
Operating income | $322.99 | $210.54 | $81.56 | $68.25 |
Income from continuing operations | ||||
EBIT | $344.6 | $220.74 | $85.94 | $88.89 |
Income tax expense | $73.08 | $37.91 | $4.2 | $24.88 |
Interest expense | $52.6 | $40.62 | $33.17 | $29.67 |
Net income | ||||
Net income | $218.92 | $142.21 | $48.57 | $34.34 |
Income (for common shares) | $218.92 | $142.21 | $48.57 | $34.34 |
(in millions $) | 27 Feb 2024 | 28 Nov 2023 | 29 Aug 2023 | 29 May 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$306.16 | -$253.51 | -$73.57 | -$33.61 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$75.91 | $111.1 | -$38.4 | -$34.06 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$123.1 | -$208.52 | -$140.81 | -$152.79 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $218.92 | $142.21 | $48.57 | $34.34 |
Operating activities | ||||
Depreciation | $198.27 | $176.25 | $184.49 | $207.72 |
Business acquisitions & disposals | -$122.9 | -$0.35 | ||
Stock-based compensation | $25.46 | $17.93 | $9.87 | $12.77 |
Total cash flows from operations | $258.98 | $164.79 | $308.65 | $381.78 |
Investing activities | ||||
Capital expenditures | -$183.26 | -$183.58 | -$151.68 | -$44.63 |
Investments | ||||
Total cash flows from investing | -$306.16 | -$183.93 | -$151.68 | -$44.63 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | -$48.51 | -$44.17 | -$103.87 | -$94.26 |
Net borrowings | -$17.5 | -$17.5 | $253.22 | -$281.28 |
Total cash flows from financing | -$75.91 | -$67.43 | $142.01 | -$383.44 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$123.1 | -$86.57 | $298.99 | -$46.3 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |